Director/Professor
Rutgers University
Disclosure: GlaxoSmithKline (Research Grant or Support)
Dr. Laura Pizzi is a seasoned evaluation scientist, and Professor and Director of the Center for Health Outcomes, Policy, and Economics at Rutgers University. For the past 20 years, she has led interdisciplinary teams of outcomes methodologists, statisticians, and clinicians to develop and conduct cost and outcome analyses on pharmacological therapies as well as a variety of non-pharmacological interventions. A particular interest is developing scientific evidence to inform the U.S. translation and implementation of cost-effective interventions to improve the quality of care for older adults. She has testified before the US House of Representatives Committee on Ways and Means on Medicare overspending in beneficiaries with end-stage renal disease. She co-edited a text (Economic Evaluation in US Healthcare: Principles and Applications, Jones and Bartlett), is Editor in Chief of Value and Outcomes Spotlight, member of the Editorial Board for PharmacoEconomics, Deputy Editor of American Health and Drug Benefits, Co-Chair of the Cross-Council Workgroup on Competencies for New Professionals in Health Economics and Outcomes Research, and Chair of the Common Economic Measures Workgroup for a new CDC-funded multi-center grant on glaucoma. She has published more than 100 peer-reviewed manuscripts and 120 peer-reviewed poster or podium presentations and has significant teaching and mentoring experience which has been recognized via faculty awards.
